Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Transpl Infect Dis. 2018 Sep 21;20(6):e12994. doi: 10.1111/tid.12994

Table 5.

Impact of immunodeficiency on 60-day mortality after RSV LRTI in HCT recipients

Immunodeficiency Grade Mortality (n=85) OR (95% CI) p-value
ISI
 Low-risk
 Moderate-risk
 High-risk
2/21 (10%)
8/43 (19%)
10/21 (48%)
1.0
2.2 (0.4–11.3)
10.5 (1.9–56.6)
-
0.36
0.01
SID criteria
 MID
 SID
 vSID
3/39 (8%)
5/19 (26%)
14/27 (52%)
1.0
4.3 (0.9–20.4)
11.1 (2.8–45.1)
-
0.07
<0.001

Abbreviation. RSV: respiratory syncytial virus; LRTI: lower respiratory tract infection; ISI: Immunodeficiency Scoring Index; MID: moderate immunodeficiency; SID: severe immunodeficiency; vSID: very severe immunodeficiency